<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380040</url>
  </required_header>
  <id_info>
    <org_study_id>181/14</org_study_id>
    <nct_id>NCT02380040</nct_id>
  </id_info>
  <brief_title>Plethismographic Perfusion Index in Neonates</brief_title>
  <official_title>Examination of Perfusion Index in Term and Preterm Newborns Through Plethismography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Photoplethismography will be measured and compared in newborns suffering from patent ductus
      arteriosus and normal controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Newborn babies admitted to the NICU and well baby will be connected to a specially designed
      photoplethismograph (PPG). Right hand (pre ductal), and and one of the legs (postductal)
      values will be compared, based on the formula Delta amplitude of PPG / baseline absorption
      (perfusion index (PI)). Normal values will be defined in healthy term and preterm babies, and
      clinical conditions in which the PI is expected to change (Patent Ductus Artheriosus,
      Persistent pulmonary hypertension of the newborn)will be compared with these normal values.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perfusion Index</measure>
    <time_frame>5 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patent Ductus Arteriosus</condition>
  <condition>Persistent Pulmonary Hypertension of the Newborn</condition>
  <arm_group>
    <arm_group_label>Term</arm_group_label>
    <description>Normal Term Newborn Intervention: PPG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm</arm_group_label>
    <description>Preterm babies admitted to the NICU not suffering from the conditions to be studied Intervention: PPG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDA</arm_group_label>
    <description>Patent Ductus Arteriosus Intervention: PPG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PPHN</arm_group_label>
    <description>Persistent Pulmonary Hypertension Intervention: PPG</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PPG</intervention_name>
    <description>A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software</description>
    <arm_group_label>Term</arm_group_label>
    <arm_group_label>Preterm</arm_group_label>
    <arm_group_label>PDA</arm_group_label>
    <arm_group_label>PPHN</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Term and Preterm newborns admitted to the neonatology department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PDA, PPHN and Normal babies who underwent echocardiography

        Exclusion Criteria:

          -  Other cardiac diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruben Bromiker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaare Zedek Medical Center, Jerusalem, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruben Bromiker, MD</last_name>
    <phone>972508685154</phone>
    <email>bromi@szmc.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Itamar Nitzan, MD</last_name>
    <phone>972507414998</phone>
    <email>itamarnitzan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ruben Bromiker</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruben Bromiker, MD</last_name>
      <phone>972508685154</phone>
      <email>bromi@smc.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Itamar Nitzan, MD</last_name>
      <phone>972507414998</phone>
      <email>itamarnitzan@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2015</study_first_submitted>
  <study_first_submitted_qc>March 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>September 4, 2016</last_update_submitted>
  <last_update_submitted_qc>September 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
    <mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

